ATRA Yanina Grant-Huerta sells $15K worth of shares
May 21, 2025, 4:34 AM
0.00%
What does ATRA do
Atara Biotherapeutics, headquartered in Thousand Oaks, California, is a biotechnology company specializing in allogeneic T-cell immunotherapy, with products like Ebvallo and ATA3219 in various development stages. The company went public on October 16, 2014, and employs 173 staff.
Yanina Grant-Huerta sold 2,218 shares of ATRA on 16 May at $6.76 per share, worth a total of $15K. They now own 37,067 ATRA shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
